BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/3/2019 7:56:59 AM | Browse: 198 | Download: 136
Publication Name World Journal of Meta-Analysis
Manuscript ID 49946
Country/Territory Greece
2019-06-27 00:24
Peer-Review Started
2019-06-29 04:07
To Make the First Decision
2019-08-02 07:03
Return for Revision
2019-08-02 09:08
2019-08-07 14:42
Second Decision
2019-08-16 12:47
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2019-08-20 03:05
Articles in Press
2019-08-20 03:05
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2019-08-27 07:38
Publish the Manuscript Online
2019-09-03 07:56
ISSN 2308-3840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology and Metabolism
Manuscript Type Review
Article Title Antidiabetic agents in patients with hepatic impairment
Manuscript Source Invited Manuscript
All Author List Athanasia Papazafeiropoulou and Αndreas Μelidonis
Author(s) ORCID Number
Athanasia Papazafeiropoulou http://orcid.org/0000-0002-7596-4942
Αndreas Μelidonis http://orcid.org/0000-0003-0505-5708
Funding Agency and Grant Number
Corresponding author Athanasia Papazafeiropoulou, MD, MSc, PhD, Attending Doctor, Research Scientist, 1st Department of Internal Medicine and Diabetes Center, Tzaneio General Hospital of Piraeus, 1 Zanni and Afentouli Street, Athens 18536, Greece. pathan@ath.forthnet.gr
Key Words Hepatic impairment; Type 2 diabetes mellitus; Pharmacokinetics; Antidiabetic drugs; ;
Core Tip Most of the antidiabetic agents, with the exception of insulin, need dosage titration due to alterations to their pharmacokinetics in patients with chronic liver disease (CLD). For well-established antidiabetic treatments, like metformin and sulfonylureas there are studies regarding their dosage chance in these patients. However, despite the growing problem of management of diabetes in patients with CLD the existing literature data, especially on newer antidiabetic agents, are limited and, furthermore, no direct guidelines exist. Therefore, in the present review article we try to summarize the existing literature data regarding management of diabetes in patients with CLD.
Publish Date 2019-09-03 07:56
Citation Pazafiropoulou A, Melidonis A. Antidiabetic agents in patients with hepatic impairment. World J Meta-Anal 2019; 7(8): 380-388
Url https://www.wjgnet.com/2308-3840/full/v7/i8/380.htm
DOI https://dx.doi.org/10.13105/wjma.v7.i8.380
Full Article (PDF) WJMA-7-380.pdf
Full Article (Word) WJMA-7-380.docx
Manuscript File 49946-Review.docx
Answering Reviewers 49946-Answering reviewers.pdf
Audio Core Tip 49946-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 49946-Conflict-of-interest statement.pdf
Copyright License Agreement 49946-Copyright license agreement.pdf
Peer-review Report 49946-Peer-review(s).pdf
Scientific Misconduct Check 49946-Scientific misconduct check.pdf
Scientific Editor Work List 49946-Scientific editor work list.pdf